Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine Cancer CDx Approved in Japan

NEW YORK (GenomeWeb) — Foundation Medicine announced today that its FoundationOne CDx genomic profiling assay has received regulatory approval from Japan's Ministry of Health, Labour and Welfare (MHLW).

The next-generation sequencing-based assay — which was approved by the US Food and Drug Administration in late 2017 — is designed to detect substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, as well as select gene rearrangements, known to drive cancer growth. It also detects genomic signatures including microsatellite instability and tumor mutational burden in DNA isolates.

According to Cambridge, Massachusetts-based Foundation Medicine, the MHLW approved FoundationOne CDx as a comprehensive genomic profiling test for all solid tumors and as a companion diagnostic for advanced cancer patients. The agency is expected to issue a reimbursement coverage decision for the assay in the first half of 2019, the company added.

"Similar to our FDA approval in the United States, the MHLW has approved FoundationOne CDx as a comprehensive genomic profiling tool for all solid tumors and a broad companion diagnostic — a first of its kind comprehensive diagnostic test for individuals living with cancer in Japan," Foundation Medicine Chief Business Officer Melanie Nallicheri said in a statement. "This is also an important milestone for our biopharma partners who can leverage FoundationOne CDx to accelerate companion diagnostic development and improve access to personalized oncology care in Japan."

Earlier this year, Foundation Medicine and Chugai Pharmaceutical — both part of Roche — signed an agreement giving Chugai the marketing rights to FoundationOne CDx in Japan.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.